[Rx] Trajenta Linagliptin 5mg – 30 Tablets for Type 2 Diabetes Management
113.40ر.س
Product description
⚕️ PRESCRIPTION REQUIRED (Rx): Trajenta (Linagliptin) is a prescription-only medication. Do not use without a valid prescription from a licensed physician. This content is for informational purposes only.
Trajenta (Linagliptin 5mg) – Advanced Type 2 Diabetes Management
Trajenta, manufactured by Boehringer Ingelheim, contains Linagliptin — a DPP-4 (Dipeptidyl Peptidase-4) inhibitor for glycemic control in adults with Type 2 Diabetes Mellitus.
Mechanism of Action: DPP-4 rapidly degrades incretin hormones (GLP-1, GIP) secreted by the gut after meals. These hormones stimulate insulin secretion and suppress glucagon. By inhibiting DPP-4, Linagliptin preserves active incretin levels, resulting in glucose-dependent insulin release and reduced postprandial hyperglycemia.
Clinical Advantage – Renal Safety: Unlike most DPP-4 inhibitors, over 90% of Linagliptin is excreted via the biliary/intestinal route, not the kidneys. This makes Trajenta suitable for patients with renal impairment without requiring dose adjustment in most cases.
Approved Uses: Type 2 Diabetes in adults — as monotherapy or in combination with metformin, insulin, or other antidiabetics, as adjunct to diet and exercise.
Standard Dose: One tablet (5mg) once daily, with or without food.
Important Warnings: Not for Type 1 Diabetes or DKA. Monitor for pancreatitis symptoms. Inform physician of all concurrent medications.
Dispensed by prescription only at Ghaydaa Medical KSA.

